China's Best One-Stop Medical Equipment Provider
About

May Health is a clinical-stage medical device company based in Paris, France, focused on developing innovative treatments for women with Polycystic Ovary Syndrome (PCOS). Founded in 2017, the company was previously known as AblaCare and has integrated with the Paris-based accelerator MD Start. The flagship product, Ovarian Rebalancing™, is a minimally invasive procedure aimed at restoring natural ovulation in individuals with PCOS. This outpatient treatment targets ovarian ablation to reduce androgen production without hormones, offering a safe alternative to current fertility options. May Health is conducting clinical trials, including the REBALANCE Study, to validate the therapy's safety and effectiveness under FDA and European Union regulations, with plans for future availability in the US and Europe. May Health's leadership team consists of experienced professionals in medtech, product development, and regulatory affairs. The company has secured significant funding to advance its clinical development and is committed to addressing broader health challenges associated with PCOS, aligning its mission with several United Nations Sustainable Development Goals.

Technologies
Gmail Outlook Google Apps Amazon AWS Facebook Custom Audiences Zoho CRM WordPress.org Bing Ads Mobile Friendly Google Tag Manager Facebook Login (Connect) Facebook Widget Remote Circle IoT AI
Keywords
medical equipment manufacturing clinical research medical equipment and supplies manufacturing clinical trial outpatient procedure safety and efficacy radiofrequency energy patient care fertility innovation women's health ovarian function restoration ovarian rebalancing fda regulatory process fertility treatment ovulation restoration women's reproductive health medical device development pcos-related infertility medical devices investigational medical device clinical investigation ovarian ablation medical device medtech ovarian tissue ablation pcos treatment healthcare minimally invasive procedure transvaginal access ovulation induction
Company Information
  • Employees 29
  • Founded 2017
  • Annual Revenue $34500000
  • Total Funding $46203780
Location

9 Rue du 4 Septembre, Paris, Ile-de-France, France, 75002

Related Companies
Companies in the same industry